Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Andrew Witty"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Andrew Witty."

4 result(s) displayed (1 - 4 of 4)


GSK shops Lucozade, Ribena brands

British biotech's noncore assets could fetch more than $1.5 billion, analysts say. Continue reading

Posted on April 25, 2013 9:45 AM




GlaxoSmithKline launches Human Genome offer

The drugs company says it won't participate in its target's formal review process Continue reading

Posted on May 9, 2012 9:23 AM




GSK's $2.6B Human Genome offer rejected

The biotech hires Goldman Sachs and Credit Suisse to explore its options after batting back its U.K. suitor. Continue reading

Posted on April 19, 2012 9:58 AM




Passing the pills

A new CEO takes over at Glaxo after a huge run-up of biotech licensing deals. How and when they work out is anyone's guess. Continue reading

Posted on June 2, 2008 12:00 PM






Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.

Video

Coming back for more

Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video

Sectors